Characteristics of post-PTCA patients of high and low SES
| High SESn=352(%) | Low SESn=278(%) | OR(95% CI) | |
| Vessel-involved (p=0.49) | |||
| SVD | 156 (44.4) | 119 (42.8) | 1 |
| DVD | 129 (36.7) | 112 (40.2) | 1.18 (0.79 to 1.63) |
| MVD | 66 (18.8) | 47 (17) | 0.86 (0.53 to 1.39) |
| Culprit vessel (p=0.95) | |||
| LAD | 198 (56.3) | 159 (57.2) | 1 |
| RCA | 114 (32.4) | 87 (31.3) | 0.95 (0.66 to 1.36) |
| LCX | 40 (11.3) | 32 (11.5) | 0.99 (0.57 to 1.70) |
| Baseline prescription pattern | |||
| Aspirin | 352 (100) | 278 (100) | |
| Antiplatelet | 352 (100) | 278 (100) | |
| Clopidogrel | 167 (47.4) | 127 (45.7) | 0.93 (0.67 to 1.29) |
| Ticagrelor | 185 (52.6) | 151 (54.3) | 1.04 (0.75 to 1.45) |
| Statin | 350 (99.4) | 277 (99.6) | 1.58 (0.08 to 3.7) |
| ACE-I | 105 (29.8) | 78 (28.1) | 0.91 (0.63 to 1.31) |
| ARBs | 108 (30.7) | 85 (30.6) | 0.99 (0.69 to 1.41) |
| β-blockers | 204 (58) | 178 (64) | 1.29 (0 .92 to 1.80) |
| Ca channel blockers | 62 (17.6) | 45 (16.2) | 0.90 (0.57 to1.40) |
| Diuretics | 79 (22.4) | 77 (27.7) | 1.32(0 .90 to1.93) |
| Nitrates | 81 (23) | 58 (20.9) | 0.88 (0.59 to 1.31) |
| Follow-up (p=0.96) | |||
| Hospital follow-up | 320 (91) | 253 (91) | 1 |
| Lost of follow-up | 32 (9.0) | 25 (9.0) | 0.9 (0.57 to 1.71) |
| Post-PCI LSM at 12 months (p<0.001) | |||
| High LSM | 182 (51.7) | 98 (35.4) | 1 |
| Medium LSM | 124 (35.2) | 113 (40.8) | 1.69 (1.18 to 2.41) |
| Low LSM | 40 (13.1) | 67 (23.8) | 2.7 (1.72 to 4.23) |
| Medical adherence (p=0.037) | |||
| High-medical adherence | 249 (83.8) | 174 (77.7) | 1 |
| Medium-medical adherence | 30 (10.1) | 22 (9.8) | 1.04 (0.58 to 1.88) |
| Low-medical adherence | 18 (6.1) | 28 (12.5) | 2.22 (1.19 4.15) |
ACE-I-Angiotensin converting enzyme - inhibitor.; ARB, angiotensin II receptor blockers; DVD-double vessel disease; LAD-left anterior descending; LCX-left circumflex; LSM-lifestyle modification; MVD- Multiple vessel diseases; RCA-right coronary artery; SES-socioeconomic status; SVD-single vessel disease